nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprazinone—Gastrointestinal ulcer haemorrhage—Methotrexate—multiple sclerosis	0.0558	0.0558	CcSEcCtD
Eprazinone—Extravasation—Cladribine—multiple sclerosis	0.0375	0.0375	CcSEcCtD
Eprazinone—Phlebitis—Cladribine—multiple sclerosis	0.0275	0.0275	CcSEcCtD
Eprazinone—Necrosis—Mitoxantrone—multiple sclerosis	0.0274	0.0274	CcSEcCtD
Eprazinone—Extravasation—Mitoxantrone—multiple sclerosis	0.0246	0.0246	CcSEcCtD
Eprazinone—Ulcer—Mitoxantrone—multiple sclerosis	0.0227	0.0227	CcSEcCtD
Eprazinone—Abscess—Prednisolone—multiple sclerosis	0.0223	0.0223	CcSEcCtD
Eprazinone—Hyperkalaemia—Mitoxantrone—multiple sclerosis	0.0211	0.0211	CcSEcCtD
Eprazinone—Necrosis—Methylprednisolone—multiple sclerosis	0.0206	0.0206	CcSEcCtD
Eprazinone—Abscess—Triamcinolone—multiple sclerosis	0.0205	0.0205	CcSEcCtD
Eprazinone—Abscess—Methylprednisolone—multiple sclerosis	0.0204	0.0204	CcSEcCtD
Eprazinone—Infection—Fingolimod—multiple sclerosis	0.0204	0.0204	CcSEcCtD
Eprazinone—Abdominal discomfort—Cladribine—multiple sclerosis	0.0197	0.0197	CcSEcCtD
Eprazinone—Necrosis—Betamethasone—multiple sclerosis	0.0187	0.0187	CcSEcCtD
Eprazinone—Necrosis—Dexamethasone—multiple sclerosis	0.0187	0.0187	CcSEcCtD
Eprazinone—Abscess—Dexamethasone—multiple sclerosis	0.0186	0.0186	CcSEcCtD
Eprazinone—Abscess—Betamethasone—multiple sclerosis	0.0186	0.0186	CcSEcCtD
Eprazinone—Phlebitis—Mitoxantrone—multiple sclerosis	0.0181	0.0181	CcSEcCtD
Eprazinone—Ulcer—Triamcinolone—multiple sclerosis	0.0171	0.0171	CcSEcCtD
Eprazinone—Extravasation—Betamethasone—multiple sclerosis	0.0169	0.0169	CcSEcCtD
Eprazinone—Extravasation—Dexamethasone—multiple sclerosis	0.0169	0.0169	CcSEcCtD
Eprazinone—Necrosis—Prednisone—multiple sclerosis	0.0163	0.0163	CcSEcCtD
Eprazinone—Abscess—Prednisone—multiple sclerosis	0.0162	0.0162	CcSEcCtD
Eprazinone—Abdominal discomfort—Azathioprine—multiple sclerosis	0.016	0.016	CcSEcCtD
Eprazinone—Hyponatraemia—Mitoxantrone—multiple sclerosis	0.0157	0.0157	CcSEcCtD
Eprazinone—Gastrointestinal haemorrhage—Mitoxantrone—multiple sclerosis	0.0156	0.0156	CcSEcCtD
Eprazinone—Ulcer—Dexamethasone—multiple sclerosis	0.0155	0.0155	CcSEcCtD
Eprazinone—Ulcer—Betamethasone—multiple sclerosis	0.0155	0.0155	CcSEcCtD
Eprazinone—Flatulence—Cladribine—multiple sclerosis	0.0141	0.0141	CcSEcCtD
Eprazinone—Diarrhoea—Fingolimod—multiple sclerosis	0.0141	0.0141	CcSEcCtD
Eprazinone—Necrosis—Methotrexate—multiple sclerosis	0.0136	0.0136	CcSEcCtD
Eprazinone—Ulcer—Prednisone—multiple sclerosis	0.0135	0.0135	CcSEcCtD
Eprazinone—Abscess—Methotrexate—multiple sclerosis	0.0135	0.0135	CcSEcCtD
Eprazinone—Extravasation—Methotrexate—multiple sclerosis	0.0123	0.0123	CcSEcCtD
Eprazinone—Infection—Cladribine—multiple sclerosis	0.0116	0.0116	CcSEcCtD
Eprazinone—Ulcer—Methotrexate—multiple sclerosis	0.0113	0.0113	CcSEcCtD
Eprazinone—Infection—Azathioprine—multiple sclerosis	0.00942	0.00942	CcSEcCtD
Eprazinone—Gastrointestinal haemorrhage—Prednisone—multiple sclerosis	0.0093	0.0093	CcSEcCtD
Eprazinone—Body temperature increased—Cladribine—multiple sclerosis	0.00922	0.00922	CcSEcCtD
Eprazinone—Diarrhoea—Cladribine—multiple sclerosis	0.00798	0.00798	CcSEcCtD
Eprazinone—Infection—Mitoxantrone—multiple sclerosis	0.00761	0.00761	CcSEcCtD
Eprazinone—Body temperature increased—Azathioprine—multiple sclerosis	0.0075	0.0075	CcSEcCtD
Eprazinone—Vomiting—Cladribine—multiple sclerosis	0.00741	0.00741	CcSEcCtD
Eprazinone—Rash—Cladribine—multiple sclerosis	0.00735	0.00735	CcSEcCtD
Eprazinone—Dermatitis—Cladribine—multiple sclerosis	0.00735	0.00735	CcSEcCtD
Eprazinone—Nausea—Cladribine—multiple sclerosis	0.00693	0.00693	CcSEcCtD
Eprazinone—Diarrhoea—Azathioprine—multiple sclerosis	0.00649	0.00649	CcSEcCtD
Eprazinone—Abdominal discomfort—Methotrexate—multiple sclerosis	0.00644	0.00644	CcSEcCtD
Eprazinone—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00606	0.00606	CcSEcCtD
Eprazinone—Vomiting—Azathioprine—multiple sclerosis	0.00603	0.00603	CcSEcCtD
Eprazinone—Rash—Azathioprine—multiple sclerosis	0.00598	0.00598	CcSEcCtD
Eprazinone—Dermatitis—Azathioprine—multiple sclerosis	0.00597	0.00597	CcSEcCtD
Eprazinone—Infection—Triamcinolone—multiple sclerosis	0.00574	0.00574	CcSEcCtD
Eprazinone—Infection—Methylprednisolone—multiple sclerosis	0.00573	0.00573	CcSEcCtD
Eprazinone—Nausea—Azathioprine—multiple sclerosis	0.00563	0.00563	CcSEcCtD
Eprazinone—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00524	0.00524	CcSEcCtD
Eprazinone—Infection—Dexamethasone—multiple sclerosis	0.00521	0.00521	CcSEcCtD
Eprazinone—Infection—Betamethasone—multiple sclerosis	0.00521	0.00521	CcSEcCtD
Eprazinone—Vomiting—Mitoxantrone—multiple sclerosis	0.00487	0.00487	CcSEcCtD
Eprazinone—Rash—Mitoxantrone—multiple sclerosis	0.00483	0.00483	CcSEcCtD
Eprazinone—Dermatitis—Mitoxantrone—multiple sclerosis	0.00483	0.00483	CcSEcCtD
Eprazinone—Body temperature increased—Triamcinolone—multiple sclerosis	0.00457	0.00457	CcSEcCtD
Eprazinone—Nausea—Mitoxantrone—multiple sclerosis	0.00455	0.00455	CcSEcCtD
Eprazinone—Infection—Prednisone—multiple sclerosis	0.00454	0.00454	CcSEcCtD
Eprazinone—Body temperature increased—Betamethasone—multiple sclerosis	0.00415	0.00415	CcSEcCtD
Eprazinone—Body temperature increased—Dexamethasone—multiple sclerosis	0.00415	0.00415	CcSEcCtD
Eprazinone—Rash—Prednisolone—multiple sclerosis	0.00396	0.00396	CcSEcCtD
Eprazinone—Dermatitis—Prednisolone—multiple sclerosis	0.00396	0.00396	CcSEcCtD
Eprazinone—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00395	0.00395	CcSEcCtD
Eprazinone—Infection—Methotrexate—multiple sclerosis	0.00379	0.00379	CcSEcCtD
Eprazinone—Nausea—Prednisolone—multiple sclerosis	0.00374	0.00374	CcSEcCtD
Eprazinone—Vomiting—Triamcinolone—multiple sclerosis	0.00368	0.00368	CcSEcCtD
Eprazinone—Vomiting—Methylprednisolone—multiple sclerosis	0.00367	0.00367	CcSEcCtD
Eprazinone—Rash—Triamcinolone—multiple sclerosis	0.00365	0.00365	CcSEcCtD
Eprazinone—Dermatitis—Triamcinolone—multiple sclerosis	0.00364	0.00364	CcSEcCtD
Eprazinone—Rash—Methylprednisolone—multiple sclerosis	0.00364	0.00364	CcSEcCtD
Eprazinone—Dermatitis—Methylprednisolone—multiple sclerosis	0.00363	0.00363	CcSEcCtD
Eprazinone—Body temperature increased—Prednisone—multiple sclerosis	0.00361	0.00361	CcSEcCtD
Eprazinone—Diarrhoea—Betamethasone—multiple sclerosis	0.00359	0.00359	CcSEcCtD
Eprazinone—Diarrhoea—Dexamethasone—multiple sclerosis	0.00359	0.00359	CcSEcCtD
Eprazinone—Nausea—Triamcinolone—multiple sclerosis	0.00343	0.00343	CcSEcCtD
Eprazinone—Nausea—Methylprednisolone—multiple sclerosis	0.00343	0.00343	CcSEcCtD
Eprazinone—Vomiting—Dexamethasone—multiple sclerosis	0.00334	0.00334	CcSEcCtD
Eprazinone—Vomiting—Betamethasone—multiple sclerosis	0.00334	0.00334	CcSEcCtD
Eprazinone—Rash—Betamethasone—multiple sclerosis	0.00331	0.00331	CcSEcCtD
Eprazinone—Rash—Dexamethasone—multiple sclerosis	0.00331	0.00331	CcSEcCtD
Eprazinone—Dermatitis—Betamethasone—multiple sclerosis	0.00331	0.00331	CcSEcCtD
Eprazinone—Dermatitis—Dexamethasone—multiple sclerosis	0.00331	0.00331	CcSEcCtD
Eprazinone—Diarrhoea—Prednisone—multiple sclerosis	0.00313	0.00313	CcSEcCtD
Eprazinone—Nausea—Betamethasone—multiple sclerosis	0.00312	0.00312	CcSEcCtD
Eprazinone—Nausea—Dexamethasone—multiple sclerosis	0.00312	0.00312	CcSEcCtD
Eprazinone—Body temperature increased—Methotrexate—multiple sclerosis	0.00302	0.00302	CcSEcCtD
Eprazinone—Vomiting—Prednisone—multiple sclerosis	0.00291	0.00291	CcSEcCtD
Eprazinone—Rash—Prednisone—multiple sclerosis	0.00288	0.00288	CcSEcCtD
Eprazinone—Dermatitis—Prednisone—multiple sclerosis	0.00288	0.00288	CcSEcCtD
Eprazinone—Nausea—Prednisone—multiple sclerosis	0.00271	0.00271	CcSEcCtD
Eprazinone—Diarrhoea—Methotrexate—multiple sclerosis	0.00261	0.00261	CcSEcCtD
Eprazinone—Vomiting—Methotrexate—multiple sclerosis	0.00243	0.00243	CcSEcCtD
Eprazinone—Rash—Methotrexate—multiple sclerosis	0.00241	0.00241	CcSEcCtD
Eprazinone—Dermatitis—Methotrexate—multiple sclerosis	0.00241	0.00241	CcSEcCtD
Eprazinone—Nausea—Methotrexate—multiple sclerosis	0.00227	0.00227	CcSEcCtD
